FOXO TECHNOLOGIES INC. Deferred State and Local Income Tax Expense (Benefit)
FOXO TECHNOLOGIES INC. (FOXO) reported Deferred State and Local Income Tax Expense (Benefit) of -$42.30 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-04-15
- FOXO TECHNOLOGIES INC. deferred state and local income tax expense (benefit) for fiscal 2025 was -$42.30K.
- FOXO TECHNOLOGIES INC. deferred state and local income tax expense (benefit) for fiscal 2023 was $1.65M, a 59.23% decline from fiscal 2022.
- FOXO TECHNOLOGIES INC. deferred state and local income tax expense (benefit) for fiscal 2022 was $4.05M, a 151.33% increase from fiscal 2021.
- FOXO TECHNOLOGIES INC. deferred state and local income tax expense (benefit) for fiscal 2021 was $1.61M.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$42.30K 10-K · filed 2026-04-15 |
| 2023-12-31 | $1.65M 10-K · filed 2024-06-06 |
| 2022-12-31 | $4.05M 10-K · filed 2024-06-06 |
| 2021-12-31 | $1.61M 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |